THE ADDITION OF RITUXIMAB TO CODOX-M/IVAC CHEMOTHERAPY IN THE TREATMENT OF BURKITT LYMPHOMA IS SAFE AND IS ASSOCIATED WITH INCREASED EFFICACY IN THE HIV POSITIVE POPULATION
dc.contributor.author | Alwan, F | en_US |
dc.contributor.author | He, A | en_US |
dc.contributor.author | Montoto, S | en_US |
dc.contributor.author | Kassam, S | en_US |
dc.contributor.author | Mee, M | en_US |
dc.contributor.author | Burns, F | en_US |
dc.contributor.author | Edwards, S | en_US |
dc.contributor.author | Wilson, A | en_US |
dc.contributor.author | Tenant-Flowers, M | en_US |
dc.contributor.author | Marcus, R | en_US |
dc.contributor.author | Ardeshna, KM | en_US |
dc.contributor.author | Bower, M | en_US |
dc.contributor.author | Cwynarski, K | en_US |
dc.date.accessioned | 2015-03-25T14:10:50Z | |
dc.date.issued | 2014-06-01 | en_US |
dc.identifier.issn | 0390-6078 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/6980 | |
dc.format.extent | 149 - 150 | en_US |
dc.title | THE ADDITION OF RITUXIMAB TO CODOX-M/IVAC CHEMOTHERAPY IN THE TREATMENT OF BURKITT LYMPHOMA IS SAFE AND IS ASSOCIATED WITH INCREASED EFFICACY IN THE HIV POSITIVE POPULATION | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342830900360&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 99 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |